Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

I-Acute Lymphoblastic Leukemia (T-ALL)-03

Isiguli: Huang XX

Ubulili: Owesilisa

Ubudala: Iminyaka engu-42 ubudala

Ubuzwe: IsiShayina

Ukuxilongwa:I-Acute Lymphoblastic Leukemia (T-ALL)

    Izici Zecala:

    - Ukuxilongwa: I-Acute T-cell lymphoblastic leukemia

    - Ukuqala kanye Nezimpawu: Ephreli 2020, kwavela isiyezi, ukukhathala, kanye namaphuzu okopha esikhumbeni. Kutholakale ukuthi une-acute T-cell lymphoblastic leukemia ngokuhlolwa kwe-bone marrow MICM.

    - Ukwelashwa Kokuqala: Uthole ukuxolelwa okuphelele (CR) ngemuva kokwelashwa ngamakhemikhali kwe-VDCLP, kulandelwa imijikelezo emibili yokwelashwa ngamakhemikhali okuqinisiwe.

    - Julayi 19, 2020: Kwatholwa ukufakelwa kwe-allogeneic hematopoietic stem cell kusuka kumnikeli wesifazane (HLA 5/10 A donor A). Uhlelo lokulungisa isimo luhlanganisa ukushiswa komzimba wonke (TBI), i-cyclophosphamide (CY), kanye ne-etoposide (VP-16). Amaseli e-peripheral stem afakwa ngoJulayi 24, kanye nokululama kwe-granulocyte ngosuku +10 kanye nokuxhunyelelwa kwama-platelet ngosuku +13. Ukulandelela njalo kweziguli zangaphandle ngemva kwalokho.

    - 25 Nhlolanja 2021: Kutholakale ukuphinda kubuye umnkantsha ngesikhathi sokulandelela.

    - Ukwelashwa: Ngaqala ukwelashwa nge-thalidomide ngomlomo.

    - Mashi 8: Ungeniswe esibhedlela sethu.

    - Ukwakheka kwe-Bone Marrow: ukuqhuma okungu-61.5%.

    - Ukuhlukaniswa Kwegazi Okungaphandle: ukuqhuma okungu-15%.

    - I-Immunophenotyping: amaseli angu-35.25% aveza i-CD99, i-CD5, i-CD3dim, i-CD8dim, i-CD7, i-cCD3, i-CD2dim, i-HLA-ABC, i-cbcl-2, i-CD81, i-CD38, okubonisa ama-T lymphocyte angakavuthwa ayingozi.

    - Ukuhlaziywa kwe-Chromosome: 46, XX [9].

    - I-Leukemia Fusion Gene: I-SIL-TAL1 fusion gene positive; isilinganiso sobuningi: I-SIL-TA.

    - Ukuguquka Kwesimila Segazi: Okubi.

    - Ukuhlaziywa kwe-Chimerism (ngemuva kwe-HSCT): Amaseli atholakala kubanikeli abalelwa ku-45.78%.

    - Mashi 11: Ukuqoqwa kwama-lymphocyte egazi angaphandle kwe-autologous ukuze kukhuliswe amangqamuzana e-CD7-CART.

    - Ukwelashwa: I-VILP (VDS 4mg, IDA 10mg, L-asparaginase 10,000 IU qd x izinsuku ezi-4, Dex 9mg q12h x izinsuku eziyi-9) ehlanganiswe ne-thalidomide ukulawula isimila.

    - Mashi 19: Ukwelashwa ngamakhemikhali kwe-FC (Umkhuhlane 50mg x izinsuku ezi-3, i-CTX 0.4gx izinsuku ezi-3).

    - Mashi 24 (ngaphambi kokufakwa): Ukwakheka komnkantsha wethambo kubonise i-grade V hyperplasia, kanye nokuqhuma okungu-22%.

    - I-Bone Marrow Flow Cytometry: amaseli angu-29.21% (amaseli ane-nucleated) aveza i-CD3, i-CD5, i-CD7, i-CD99, aveza i-cCD3 ngokwengxenye, okubonisa amaseli e-T angakavuthwa ayingozi.

    - I-Quantitative SIL-TAL1 Fusion Gene: 1.913%.

    25dho

    Ukwelashwa:
    - Mashi 26: Ukufakwa kwamaseli e-CD7-CART e-autologous (5*10^5/kg)
    - Imiphumela Engemihle Ehlobene ne-CAR-T: Ibanga 1 le-CRS (umkhuhlane), akukho ubuthi be-neurological
    - Ephreli 12 (Usuku lwe-17): Ukulandelela kubonise isimo somnkantsha wamathambo ekukhululweni, awekho amangqamuzana angakavuthwa atholakala nge-flow cytometry, kanye nokulinganiswa kwezakhi zofuzo ze-SIL-TAL1 (STIL-SCL) ku-0

    26i6g

    incazelo2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write